Insmed | INSM - Debt

Stock Price
156.24
Daily Change
3.80 2.49%
Monthly
-10.76%
Yearly
93.41%
Q1 Forecast
152.04

Insmed reported $564.56M in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
BioMarin Pharmaceutical USD 603.87M 8.22M Jun/2025
Cytokinetics USD 858.06M 199.93M Jun/2025
DBV Technologies USD 8.59M 295K Sep/2025
Dynavax Technologies USD 285.5M 24.99M Jun/2025
Gilead Sciences USD 24.95B 6M Jun/2025
Insmed USD 564.56M 464K Sep/2025
Novartis USD 32.02B 615M Sep/2025
Regeneron Pharmaceuticals USD 2.71B 400K Sep/2025
Sarepta Therapeutics USD 1.35B 215.59M Jun/2025
Ultragenyx Pharmaceutical USD 36.3M 1.98M Jun/2025
Vertex Pharmaceuticals USD 1.53B 121.7M Jun/2025